New patent for Boehringer Ingelheim drug TRADJENTA

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are eight patents…

Source


Comments are closed.

Biotechblog